Opioid Use and Predicting Factors at the Emergency Department
VRxOPUS-1
1 other identifier
observational
149
1 country
1
Brief Summary
Background: Increasing opioid misuse is a worldwide problem. About 10% of opioid misusers are primarily exposed to opioids at the Emergency Department (ED). This study was conducted to determine the feasibility for a clinical trial investigating the effect of Virtual Reality therapy on opioid consumption at the ED. Methods: Adult patients were included when primarily seen by the Emergency Physician and presenting with a NRS pain score ≥4. Main objective was to identify the target population and evaluate outcome measures to sustain a trial incorporating the Oral Morphine Equivalent (OME) at the ED as the primary endpoint. Primary outcome was mean OME administered at the ED. Secondary outcomes included NRS pain scores, main symptoms and type of analgesics administered at the ED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2023
CompletedFirst Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedOctober 10, 2023
September 1, 2023
7 months
September 18, 2023
October 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opioid use
Opioids use of patients during their stay at Emergency Department (yes/no)
throughout study participation, up to 8 hours
Secondary Outcomes (12)
Oral morphine equivalent
throughout study participation, up to 8 hours
Administered analgesics
throughout study participation, up to 8 hours
Pain acceptability
Asked at moment of admittance and at discharge, up to 6 hours after inclusion
Reason why patients finds pain acceptable
Assessed upon admittance
Patients desire for analgesics
Asked at moment of admittance and at discharge, up to 6 hours after inclusion
- +7 more secondary outcomes
Study Arms (1)
Patient with NRS pain at rest being 4 or higher
Patient with NRS pain at rest being 4 or higher, primarily treated by emergency physician, internist, or surgeon. All patients receive usual care, no interventions are administered.
Interventions
Eligibility Criteria
We aim to include all patients ≥16 years, who are admitted to the ED of the Radboudumc and primarily seen by an ED physician.
You may qualify if:
- Patient ≥16 years admitted to ED and identified by an Emergency Physician (EP)
- NRS pain score ≥4
- Patient is willing and able to comply with the study protocol
You may not qualify if:
- Patients initially treated by another physician than the EP.
- EMV \< 14
- History of dementia, seizures
- Severe hearing/visual impairment not corrected
- Headwounds or damaged skin with which comfortable and hygienic use is not possible.
- Presentation to ED because of chronic pain (≥3 months) exacerbation
- Chronic opioids use (≥3 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud university medical center
Nijmegen, Gelderland, 6525 GA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2023
First Posted
October 10, 2023
Study Start
February 13, 2023
Primary Completion
September 4, 2023
Study Completion
September 4, 2023
Last Updated
October 10, 2023
Record last verified: 2023-09